Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Medicinal Cannabis – harms or benefits? Who decides?

Wellington campus

Wednesday, 21 December 2016 9:25am

Giles Newton-Howes
Dr Giles Newton-Howes

Wellington researchers are calling for doctors to be more involved in the debate around cannabis as a medicine.

In a recent article in the New Zealand Medical Journal, Dr Giles Newton-Howes, from the University of Otago, Wellington, and Dr Sam McBride, from the Capital & Coast District Health Board, say that although cannabis has a long history of medicinal use, the current evidence is mixed and relatively weak.

They note though that the harms of cannabis have been well identified, and say this raises concerns about cannabis as a medication and demonstrates the importance of it undergoing the usual regulatory process for medicines.

“There is evidence around the harms and problems of using cannabis but the evidence of its effectiveness as a medicine is weak,” says Dr Giles Newton-Howes, from the Department of Psychological Medicine at the University of Otago, Wellington.

“There are also added complexities with the use of cannabis as it is illicit. We believe doctors, i.e. the people who will be asked to prescribe this medication, need to be more engaged in the discussion of medicinal cannabis to move the debate forward,” says Dr Newton-Howes.

“There has been increased interest in cannabis as a medicine both nationally and internationally. Many countries have accepted cannabis as a medication for a variety of purposes, and this has led for calls for it to be medicalised in New Zealand,” he says.

But Dr Newton-Howes says there are issues with this approach to accessing cannabis, which is why he believes doctors need to be at the forefront of the debate surround medicalised cannabis.

“If they do not engage in this debate, the medical profession will risk having to respond to requests after the fact, as opposed to helping to shape policy now. All doctors should have an interest in this, from primary care physicians to sub-specialists in neurology, psychiatry and associated fields,” he says.

“We really need to separate out the use of cannabis for medicinal purposes and recreational purposes,” says Dr Newton-Howes. If clinicians are not engaged in this debate now, we cannot influence the direction the use of cannabis will go in.

Please contact Dr Newton-Howes for a copy of the full NZMJ article.

For further information, contact:

Dr Giles Newton-Howes
Department of Psychological Medicine
University of Otago, Wellington
Tel: 64 4 385 5587
Email: giles.newton-howes@otago.ac.nz

A list of Otago experts available for media comment is available elsewhere on this website.

Electronic addresses (including email accounts, instant messaging services, or telephone accounts) published on this page are for the sole purpose of contact with the individuals concerned, in their capacity as officers, employees or students of the University of Otago, or their respective organisation. Publication of any such electronic address is not to be taken as consent to receive unsolicited commercial electronic messages by the address holder.